Vanguard Group
AVNR

Vanguard Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Vanguard Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,989,968
Closed -$152M – 4210
2014
Q4 		$152M Buy
8,989,968
+3,370,205
+60% +$47.4M 0.01% 1135
2014
Q3 		$67M Buy
5,619,763
+1,037,202
+23% +$7.08M 0.01% 1633
2014
Q2 		$25.8M Sell
4,582,561
-86,068
-2% -$397K ﹤0.01% 2120
2014
Q1 		$17.1M Buy
4,668,629
+324,799
+7% +$1.24M ﹤0.01% 2245
2013
Q4 		$14.6M Buy
4,343,830
+134,173
+3% +$554K ﹤0.01% 2298
2013
Q3 		$17.8M Buy
4,209,657
+94,285
+2% +$447K ﹤0.01% 2153
2013
Q2 		$18.9M Buy
+4,115,372
New +$14.1M ﹤0.01% 2088

Vanguard Group's AVNR Position: Q1 2015 in Review

Vanguard Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 8,989,968 shares — an estimated $152M sold.

Vanguard Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $152M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Vanguard Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Vanguard Group sold 8,989,968 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $152M.
  • Vanguard Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Vanguard Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $152M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.